Skip Navigation Archive: U.S. Department of Health and Human Services www.hhs.gov
Archive: Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner

Very Few Students in American Medical Schools Receive Training about Adverse Drug Events

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Press Release Date: September 4, 2001

Only 16 percent of internal medicine clerkship programs include formal lectures about adverse drug events, according to a new study published in the September 5, 2001, issue of the Journal of the American Medical Association. Study results indicate that medical students in the United States have little exposure to information on adverse drug events in the curriculum used during their internal medicine rotation.

The study, sponsored by the U.S. Agency for Healthcare Research and Quality (AHRQ), with additional funding from the Food and Drug Administration, (FDA) also found that:

  • 35 percent of clerkship directors had little or no familiarity with the 1999 Institute of Medicine report on medical errors, To Err is Human: Building a Safer Health System.
  • After reading a brief summary of the report, 83 percent of clerkship directors said that heightened surveillance and training should occur to help decrease adverse drug events.
  • 65 percent of the clerkship directors said that they would incorporate 1 or 2 hours of educational materials on adverse drug events if slide shows or Internet-based educational modules were available.
  • Only 41 percent of clerkship directors would welcome an outside speaker to lecture on the topic.

The study was carried out by AHRQ's Center for Education and Research on Therapeutics (CERTs) at Georgetown University, and it is based on a survey of 79 United States internal medicine clerkship programs that was conducted in the spring of 2000. Internal medicine clerkship programs were chosen for the survey because medical students spend an average of 12 weeks on this rotation, more than any other required clinical experience during their medical training. The study did not assess the impact of the lack of information on adverse drug events on their training overall.

Note to Editors: Details of the study are in "Survey of Medication Errors Education During Internal Medicine Clerkships," published in the Research Letter section in the September 5, 2001, issue of JAMA. To interview the authors, contact Bradford Stone, FDA Press Office at (301) 827-6250. CERTs, administered by AHRQ, aims to provide objective, complete, accessible information about the best ways to use medical products so that they can take action to improve health.

For more information, please contact Karen Migdail, (301) 427-1855 (KMigdail@ahrq.gov).


 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care